Cyclopentenone derivatives for cancer therapy

US7179937B2 · kind B2 · utility

Assignee

• DABUR RESEARCH FOUNDATION. · IN

Inventors

• Mukund Keshao Gurjar · Jamkhed, IN
• Radhika Dilip Wakharkar · Pune, IN
• Gautam Desiraju · Hyderabad, IN
• Ashwini Nangia · Hyderabad, IN
• Jhillu Singh Yadav · Darsi, IN
• Anand C. Burman · Ghaziabad, IN
• Rama Mukherjee · Sidhauli, IN
• Hanumant Bapu Rao Borate · Pune, IN
• Srivari Chandrasekhar · Hyderabad, IN
• Manu Jaggi · Barwala, IN
• Anuo T. Singh · Ghaziabad, IN
• Kamal Kishore Kapoor · Jammu, IN
• Sanjay Sarkhel · Hyderabad, IN
• K. V. V. M. Sairam · Hyderabad, IN

Key dates

• Filing date: Dec 4, 2002
• Grant date: Feb 20, 2007
• Expiry date: Oct 9, 2023

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07C2601/10
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The invention relates to the use of derivatives of cyclopentenone for the inhibition or prevention of the growth or multiplication of cancer cells, and to therapeutic compositions containing such compounds. The invention relates more specifically to the use of derivatives of cyclopentenone for the inhibition and/or prevention of cancer of the colon, pancreas, larynx, ovary, duodenum, kidney, oral cavity, prostate, lung, endothelial cells and leukemias.